Table of Content

1 Dermatomycoses Drug Market Overview
1.1 Dermatomycoses Drug Product Overview
1.2 Dermatomycoses Drug Market Segment by Type
1.2.1 BB-2603
1.2.2 Clotrimazole
1.2.3 Dapaconazole
1.2.4 Others
1.3 Global Dermatomycoses Drug Market Size by Type
1.3.1 Global Dermatomycoses Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Dermatomycoses Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Dermatomycoses Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dermatomycoses Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Dermatomycoses Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Dermatomycoses Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Dermatomycoses Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Dermatomycoses Drug Sales Breakdown by Type (2018-2024)
2 Global Dermatomycoses Drug Market Competition by Company
2.1 Global Top Players by Dermatomycoses Drug Sales (2018-2024)
2.2 Global Top Players by Dermatomycoses Drug Revenue (2018-2024)
2.3 Global Top Players by Dermatomycoses Drug Price (2018-2024)
2.4 Global Top Manufacturers Dermatomycoses Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dermatomycoses Drug Market Competitive Situation and Trends
2.5.1 Dermatomycoses Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Dermatomycoses Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatomycoses Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Dermatomycoses Drug Market
2.8 Key Manufacturers Dermatomycoses Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dermatomycoses Drug Status and Outlook by Region
3.1 Global Dermatomycoses Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Dermatomycoses Drug Historic Market Size by Region
3.2.1 Global Dermatomycoses Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Dermatomycoses Drug Sales in Value by Region (2018-2024)
3.2.3 Global Dermatomycoses Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Dermatomycoses Drug Forecasted Market Size by Region
3.3.1 Global Dermatomycoses Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Dermatomycoses Drug Sales in Value by Region (2024-2034)
3.3.3 Global Dermatomycoses Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Dermatomycoses Drug by Application
4.1 Dermatomycoses Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Dermatomycoses Drug Market Size by Application
4.2.1 Global Dermatomycoses Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Dermatomycoses Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Dermatomycoses Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dermatomycoses Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Dermatomycoses Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Dermatomycoses Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Dermatomycoses Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Dermatomycoses Drug Sales Breakdown by Application (2018-2024)
5 North America Dermatomycoses Drug by Country
5.1 North America Dermatomycoses Drug Historic Market Size by Country
5.1.1 North America Dermatomycoses Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Dermatomycoses Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Dermatomycoses Drug Sales in Value by Country (2018-2024)
5.2 North America Dermatomycoses Drug Forecasted Market Size by Country
5.2.1 North America Dermatomycoses Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Dermatomycoses Drug Sales in Value by Country (2024-2034)
6 Europe Dermatomycoses Drug by Country
6.1 Europe Dermatomycoses Drug Historic Market Size by Country
6.1.1 Europe Dermatomycoses Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Dermatomycoses Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Dermatomycoses Drug Sales in Value by Country (2018-2024)
6.2 Europe Dermatomycoses Drug Forecasted Market Size by Country
6.2.1 Europe Dermatomycoses Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Dermatomycoses Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Dermatomycoses Drug by Region
7.1 Asia-Pacific Dermatomycoses Drug Historic Market Size by Region
7.1.1 Asia-Pacific Dermatomycoses Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Dermatomycoses Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Dermatomycoses Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Dermatomycoses Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Dermatomycoses Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Dermatomycoses Drug Sales in Value by Region (2024-2034)
8 Latin America Dermatomycoses Drug by Country
8.1 Latin America Dermatomycoses Drug Historic Market Size by Country
8.1.1 Latin America Dermatomycoses Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Dermatomycoses Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Dermatomycoses Drug Sales in Value by Country (2018-2024)
8.2 Latin America Dermatomycoses Drug Forecasted Market Size by Country
8.2.1 Latin America Dermatomycoses Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Dermatomycoses Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Dermatomycoses Drug by Country
9.1 Middle East and Africa Dermatomycoses Drug Historic Market Size by Country
9.1.1 Middle East and Africa Dermatomycoses Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Dermatomycoses Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Dermatomycoses Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Dermatomycoses Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Dermatomycoses Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Dermatomycoses Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Anacor Pharmaceuticals Inc
10.1.1 Anacor Pharmaceuticals Inc Company Information
10.1.2 Anacor Pharmaceuticals Inc Introduction and Business Overview
10.1.3 Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Anacor Pharmaceuticals Inc Dermatomycoses Drug Products Offered
10.1.5 Anacor Pharmaceuticals Inc Recent Development
10.2 Biolab Farmaceutica Ltda
10.2.1 Biolab Farmaceutica Ltda Company Information
10.2.2 Biolab Farmaceutica Ltda Introduction and Business Overview
10.2.3 Biolab Farmaceutica Ltda Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Biolab Farmaceutica Ltda Dermatomycoses Drug Products Offered
10.2.5 Biolab Farmaceutica Ltda Recent Development
10.3 Blueberry Therapeutics Ltd
10.3.1 Blueberry Therapeutics Ltd Company Information
10.3.2 Blueberry Therapeutics Ltd Introduction and Business Overview
10.3.3 Blueberry Therapeutics Ltd Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Blueberry Therapeutics Ltd Dermatomycoses Drug Products Offered
10.3.5 Blueberry Therapeutics Ltd Recent Development
10.4 Daewoong Pharmaceutical Co Ltd
10.4.1 Daewoong Pharmaceutical Co Ltd Company Information
10.4.2 Daewoong Pharmaceutical Co Ltd Introduction and Business Overview
10.4.3 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Products Offered
10.4.5 Daewoong Pharmaceutical Co Ltd Recent Development
10.5 Dermala Inc
10.5.1 Dermala Inc Company Information
10.5.2 Dermala Inc Introduction and Business Overview
10.5.3 Dermala Inc Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Dermala Inc Dermatomycoses Drug Products Offered
10.5.5 Dermala Inc Recent Development
10.6 Helix BioMedix Inc
10.6.1 Helix BioMedix Inc Company Information
10.6.2 Helix BioMedix Inc Introduction and Business Overview
10.6.3 Helix BioMedix Inc Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Helix BioMedix Inc Dermatomycoses Drug Products Offered
10.6.5 Helix BioMedix Inc Recent Development
10.7 Novan Inc
10.7.1 Novan Inc Company Information
10.7.2 Novan Inc Introduction and Business Overview
10.7.3 Novan Inc Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Novan Inc Dermatomycoses Drug Products Offered
10.7.5 Novan Inc Recent Development
10.8 Sol-Gel Technologies Ltd
10.8.1 Sol-Gel Technologies Ltd Company Information
10.8.2 Sol-Gel Technologies Ltd Introduction and Business Overview
10.8.3 Sol-Gel Technologies Ltd Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sol-Gel Technologies Ltd Dermatomycoses Drug Products Offered
10.8.5 Sol-Gel Technologies Ltd Recent Development
10.9 TGV-Laboratories
10.9.1 TGV-Laboratories Company Information
10.9.2 TGV-Laboratories Introduction and Business Overview
10.9.3 TGV-Laboratories Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 TGV-Laboratories Dermatomycoses Drug Products Offered
10.9.5 TGV-Laboratories Recent Development
10.10 Viamet Pharmaceuticals Inc
10.10.1 Viamet Pharmaceuticals Inc Company Information
10.10.2 Viamet Pharmaceuticals Inc Introduction and Business Overview
10.10.3 Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Viamet Pharmaceuticals Inc Dermatomycoses Drug Products Offered
10.10.5 Viamet Pharmaceuticals Inc Recent Development
10.11 Vyome Biosciences Pvt Ltd
10.11.1 Vyome Biosciences Pvt Ltd Company Information
10.11.2 Vyome Biosciences Pvt Ltd Introduction and Business Overview
10.11.3 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Products Offered
10.11.5 Vyome Biosciences Pvt Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dermatomycoses Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dermatomycoses Drug Industrial Chain Analysis
11.4 Dermatomycoses Drug Market Dynamics
11.4.1 Dermatomycoses Drug Industry Trends
11.4.2 Dermatomycoses Drug Market Drivers
11.4.3 Dermatomycoses Drug Market Challenges
11.4.4 Dermatomycoses Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dermatomycoses Drug Distributors
12.3 Dermatomycoses Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of BB-2603
Table 2. Major Company of Clotrimazole
Table 3. Major Company of Dapaconazole
Table 4. Major Company of Others
Table 5. Global Dermatomycoses Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Dermatomycoses Drug Sales by Type (2018-2024) & (K Units)
Table 7. Global Dermatomycoses Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Dermatomycoses Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Dermatomycoses Drug Market Share in Value by Type (2018-2024)
Table 10. Global Dermatomycoses Drug Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Dermatomycoses Drug Sales by Type (2024-2034) & (K Units)
Table 12. Global Dermatomycoses Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Dermatomycoses Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Dermatomycoses Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Dermatomycoses Drug Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Dermatomycoses Drug Sales by Type (2018-2024) & (K Units)
Table 17. North America Dermatomycoses Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Dermatomycoses Drug Sales (K Units) by Type (2018-2024)
Table 19. Europe Dermatomycoses Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Dermatomycoses Drug Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Dermatomycoses Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Dermatomycoses Drug Sales (K Units) by Type (2018-2024)
Table 23. Latin America Dermatomycoses Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Dermatomycoses Drug Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Dermatomycoses Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Dermatomycoses Drug Sales by Company (2018-2024) & (K Units)
Table 27. Global Dermatomycoses Drug Sales Share by Company (2018-2024)
Table 28. Global Dermatomycoses Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Dermatomycoses Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Dermatomycoses Drug Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Dermatomycoses Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Dermatomycoses Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatomycoses Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Dermatomycoses Drug Market
Table 35. Key Manufacturers Dermatomycoses Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Dermatomycoses Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Dermatomycoses Drug Sales by Region (2018-2024) & (K Units)
Table 39. Global Dermatomycoses Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Dermatomycoses Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Dermatomycoses Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Dermatomycoses Drug Sales by Region (2024-2034) & (K Units)
Table 44. Global Dermatomycoses Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Dermatomycoses Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Dermatomycoses Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Dermatomycoses Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Dermatomycoses Drug Sales by Application (2018-2024) & (K Units)
Table 50. Global Dermatomycoses Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Dermatomycoses Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Dermatomycoses Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Dermatomycoses Drug Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Dermatomycoses Drug Sales by Application (2024-2034) & (K Units)
Table 55. Global Dermatomycoses Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Dermatomycoses Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Dermatomycoses Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Dermatomycoses Drug Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Dermatomycoses Drug Sales by Application (2018-2024) (K Units)
Table 60. North America Dermatomycoses Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Dermatomycoses Drug Sales by Application (2018-2024) (K Units)
Table 62. Europe Dermatomycoses Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Dermatomycoses Drug Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Dermatomycoses Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Dermatomycoses Drug Sales by Application (2018-2024) (K Units)
Table 66. Latin America Dermatomycoses Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Dermatomycoses Drug Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Dermatomycoses Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Dermatomycoses Drug Sales by Country (2018-2024) & (K Units)
Table 70. North America Dermatomycoses Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Dermatomycoses Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Dermatomycoses Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Dermatomycoses Drug Sales by Country (2024-2034) & (K Units)
Table 74. North America Dermatomycoses Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Dermatomycoses Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Dermatomycoses Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Dermatomycoses Drug Sales by Country (2018-2024) & (K Units)
Table 78. Europe Dermatomycoses Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Dermatomycoses Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Dermatomycoses Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Dermatomycoses Drug Sales by Country (2024-2034) & (K Units)
Table 82. Europe Dermatomycoses Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Dermatomycoses Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Dermatomycoses Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Dermatomycoses Drug Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Dermatomycoses Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Dermatomycoses Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Dermatomycoses Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Dermatomycoses Drug Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Dermatomycoses Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Dermatomycoses Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Dermatomycoses Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Dermatomycoses Drug Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Dermatomycoses Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Dermatomycoses Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Dermatomycoses Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Dermatomycoses Drug Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Dermatomycoses Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Dermatomycoses Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Dermatomycoses Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Dermatomycoses Drug Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Dermatomycoses Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Dermatomycoses Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Dermatomycoses Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Dermatomycoses Drug Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Dermatomycoses Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Dermatomycoses Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Dermatomycoses Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Anacor Pharmaceuticals Inc Company Information
Table 110. Anacor Pharmaceuticals Inc Introduction and Business Overview
Table 111. Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Anacor Pharmaceuticals Inc Dermatomycoses Drug Product
Table 113. Anacor Pharmaceuticals Inc Recent Development
Table 114. Biolab Farmaceutica Ltda Company Information
Table 115. Biolab Farmaceutica Ltda Introduction and Business Overview
Table 116. Biolab Farmaceutica Ltda Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Biolab Farmaceutica Ltda Dermatomycoses Drug Product
Table 118. Biolab Farmaceutica Ltda Recent Development
Table 119. Blueberry Therapeutics Ltd Company Information
Table 120. Blueberry Therapeutics Ltd Introduction and Business Overview
Table 121. Blueberry Therapeutics Ltd Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Blueberry Therapeutics Ltd Dermatomycoses Drug Product
Table 123. Blueberry Therapeutics Ltd Recent Development
Table 124. Daewoong Pharmaceutical Co Ltd Company Information
Table 125. Daewoong Pharmaceutical Co Ltd Introduction and Business Overview
Table 126. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Product
Table 128. Daewoong Pharmaceutical Co Ltd Recent Development
Table 129. Dermala Inc Company Information
Table 130. Dermala Inc Introduction and Business Overview
Table 131. Dermala Inc Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Dermala Inc Dermatomycoses Drug Product
Table 133. Dermala Inc Recent Development
Table 134. Helix BioMedix Inc Company Information
Table 135. Helix BioMedix Inc Introduction and Business Overview
Table 136. Helix BioMedix Inc Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Helix BioMedix Inc Dermatomycoses Drug Product
Table 138. Helix BioMedix Inc Recent Development
Table 139. Novan Inc Company Information
Table 140. Novan Inc Introduction and Business Overview
Table 141. Novan Inc Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Novan Inc Dermatomycoses Drug Product
Table 143. Novan Inc Recent Development
Table 144. Sol-Gel Technologies Ltd Company Information
Table 145. Sol-Gel Technologies Ltd Introduction and Business Overview
Table 146. Sol-Gel Technologies Ltd Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Sol-Gel Technologies Ltd Dermatomycoses Drug Product
Table 148. Sol-Gel Technologies Ltd Recent Development
Table 149. TGV-Laboratories Company Information
Table 150. TGV-Laboratories Introduction and Business Overview
Table 151. TGV-Laboratories Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. TGV-Laboratories Dermatomycoses Drug Product
Table 153. TGV-Laboratories Recent Development
Table 154. Viamet Pharmaceuticals Inc Company Information
Table 155. Viamet Pharmaceuticals Inc Introduction and Business Overview
Table 156. Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Viamet Pharmaceuticals Inc Dermatomycoses Drug Product
Table 158. Viamet Pharmaceuticals Inc Recent Development
Table 159. Vyome Biosciences Pvt Ltd Company Information
Table 160. Vyome Biosciences Pvt Ltd Introduction and Business Overview
Table 161. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Product
Table 163. Vyome Biosciences Pvt Ltd Recent Development
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Dermatomycoses Drug Market Trends
Table 167. Dermatomycoses Drug Market Drivers
Table 168. Dermatomycoses Drug Market Challenges
Table 169. Dermatomycoses Drug Market Restraints
Table 170. Dermatomycoses Drug Distributors List
Table 171. Dermatomycoses Drug Downstream Customers
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatomycoses Drug Product Picture
Figure 2. Global Dermatomycoses Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Dermatomycoses Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Dermatomycoses Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of BB-2603
Figure 6. Global BB-2603 Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Clotrimazole
Figure 8. Global Clotrimazole Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Dapaconazole
Figure 10. Global Dapaconazole Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Dermatomycoses Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Dermatomycoses Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Dermatomycoses Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Dermatomycoses Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Dermatomycoses Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Dermatomycoses Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Dermatomycoses Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Dermatomycoses Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Dermatomycoses Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Dermatomycoses Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Dermatomycoses Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Dermatomycoses Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermatomycoses Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermatomycoses Drug Revenue in 2022
Figure 27. Dermatomycoses Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Dermatomycoses Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Dermatomycoses Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Dermatomycoses Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Dermatomycoses Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Dermatomycoses Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Dermatomycoses Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Dermatomycoses Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Dermatomycoses Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Dermatomycoses Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Dermatomycoses Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Dermatomycoses Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Dermatomycoses Drug Manufacturing Cost Structure
Figure 47. Dermatomycoses Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed